This study aims to discover the immunomodulatory potential of the ethanol extract (EE) and the ethyl acetate fraction (EAF) of Curcuma heyneana Valeton and Zijp (Indonesian name: temu giring) rhizome using mice models. The affinity of the curcuminoid (curcumin, dimethoxy-, and bisdemethoxy-) through the Transient Receptor Potential Vanilloid 1 (TRPV1) was determined using Mollegro molecular docking in silico. The curcuminoid concentration of the EE and EAF of C. heyneana rhizome were determined using thin-layer chromatography densitometry. In vivo studies in mice models were conducted using the carbon clearance method to determine the phagocytosis index, and the number of leukocytes in the blood and spleen. Forty mice were divided into eight groups, including negative control (given 1% CMC-Na), positive control (given Stimuno Forte® suspension at a dose of 6.5 mg/kg BW), three groups given the EAF of C. heyneana rhizome extract at a dose of 125 mg/kg BW, 250 mg/kg BW, and 500 mg/kg BW, respectively, and three groups were given EE of temu giring rhizome extract with doses of 125 mg/kg BW, 250 mg/kg BW, and 500 mg/kg BW, respectively. E.E. and E.A.F. of C. heyneana (temu giring) rhizome extract contained dimethoxy curcumin (0.176 ± 0.01 and 4.53 ± 0.02 %b/b) greater than another curcuminoid, bisdemetoxy curcumin and curcumin. EE at 125 mg/kg BW and EAF dose at 500 mg/kg B W. of temu giring rhizome have immunostimulant activity with a phagocytosis index value of >1 compared to the negative control (p < 0.05). Additionally, both increase the number of lymphocytes, monocytes, and neutrophil cells in peripheral blood and spleen compared to the negative control (p < 0.05). Their activity was seen as similar to the positive control. Therefore, the EE of C. heyneana rhizome has immunostimulant activity, and the EAF of C. heyneana rhizome has immunosuppressant activity at 125 mg/kg BW and immunostimulant at a higher dose. The activity of temu giring as an immunomodulator was associataed with its affinity to TRPV1.
Diabetes mellitus prevalence in Indonesia reached 19.5 million cases, which has affected the productive age population. The indigenous people of Indonesia are blessed with the second largest biodiversity in the world, including vegetables, which are also prepared as medicaments. Vegetables are well-known as natural antioxidants which evolved in metabolic disease prevention, including diabetes mellitus. One of the Government of Indonesia’s strategic plans in health is to develop new antidiabetic from nature. In this study, nineteen vegetable species were collected and evaluated for their antioxidant activity followed by computational-based bioprospecting. The study indicated Ipomoea aquatica, Paederia foetida, Plumbago zeylanica, Nauclea pallida, Sauropus androgynus, Wrightia pubescens, and Psophocarpus tetragonolobus to contain high antioxidant components. Computational experiments on chemical constituents previously reported from the same species showed potent compounds with high affinity against α-glucosidase (3a4a). 7-O-β-D-glucopyranosyl-dihydroquercetin-3-O-α-D-glucopyranoside 1, stigmasterol 7, and chitanone 12 are the most potent compounds from Ipomoea aquatica, Paederia foetida, and Plumbago zeylanica, respectively, which are superior to a standard drug, acarbose. The four vegetable species are feasible for conventional drug sources or developed as botanical dosage according to the Indonesian government’s strategic plan. Further studies are necessary to ensure adequate preclinical and clinical data to meet the requirement of safe and potent medicine. Nevertheless, Nauclea pallida and Psophocarpus tetragonolobus are valuable species with potent yet understudied antioxidant sources.
Introduction: Dyslipidemia is a risk factor for atherosclerosis and cardiovascular disease. The high prevalence of dyslipidemia triggers the development of green coffee supplement products, which are claimed as cholesterol-lowering and slimming agents. Nonetheless, research data on the effect of taking green coffee supplement products, especially regarding cardiovascular function, is limited. Aims: To determine the potential effect of green coffee extract (GCE) on improving atherogenic index of plasma (AIP) and cardiac histopathology in hyperlipidemic rats. Methods: 24 rats were induced by high-fat feed for 21 days. Then, the rats were treated with a GCE, dose of 200, 400, and 800 mg/kg bodyweight for 14 days. The next day, blood was collected from the rats to take measurements of their serum lipid profile and calculating their AIP. The heart organ was created by using histopathological preparations. Results: Administration of GCE in all doses significantly reduced the AIP and improved cardiac histopathology in the hyperlipidemic rats. Conclusions: GCE can be developed as a cardio-protector.
Endothelial dysfunction has been considered as one of the key initial events in the pathogenesis of atherosclerosis and other cardiovascular diseases (CVDs). Several studies imply that chronic inflammation and oxidative stress play a critical role in endothelial dysfunction. The present study was designed to evaluate the preventive effect of alpha-lipoic acid (ALA) on lipopolysaccharide (LPS) induced endothelial dysfunction in rat based on malondialdehyde (MDA) level and vascular cell adhesion molecules-1 (VCAM-1) expression. Thirty Wistar rats were administered ALA for 2 weeks in different doses (30, 60, 120 mg.kg-1 BW) 1 hour before LPS 0.5 mg.kg-1 BW i.p challenge. The LPS was injected on 1st, 4th, and 9th day. MDA plasma level was analyzed with spectrophotometer λ 529 nm, and VCAM-1 expression was determined by immunohistochemistry. Pretreatment with ALA for 14 days could decrease plasma MDA level on LPS-induced endothelial dysfunction in rats. However, only one group of ALA doses, 120 mg.kg-1 BW, showed significant difference with LPS untreated group statistically. It was also found that ALA, in all treatment groups, could attenuate VCAM-1 expression. These findings suggest that ALA had a protective effect against endothelial dysfunction and may potentially prevent vascular inflammatory disease.
Background: Biodiversity is the main asset in traditional medicine development in Indonesia. Robusta green coffee has been widely studied for its activity, such as anti-hyperlipidemia, anti-obesity, and as a weight loss agent. Many products of green coffee extract are available on the market, but its toxicity data is still limited. This encourages toxicity tests to prove its safety, especially in the liver, the main organ in xenobiotic metabolism. Objective: To obtain acute and sub-chronic toxicity data of green coffee extract. Method: Robusta green coffee extract was obtained by the maceration method using 96% ethanol. Acute and sub-chronic toxicity testing refers to the OECD 432 and 407 methods. Rats were treated with green coffee extract at various dosages using oral gavage (2000 and 5000 mg/kg BW for acute dose and 250, 500, and 1000 mg/kg BW for sub-chronic toxicity test). In the acute toxicity study, green coffee extract was given once only. Observation was carried out for the first 24 hours until 14 days after, while treatment and observation in the sub-chronic toxicity test were conducted everyday for 28 days. Data collected in this study included number of deaths, physical condition, SGOT/SGPT level, gross morphology, and liver histopathology. Result: Green coffee extract had an LD50 cut-off of 2000 mg/kg BW which was categorised as a mild toxicity level. No liver function parameter changes were observed in acute and sub-chronic toxicity tests. Conclusion: Green coffee extract is safe and can be further developed in herbal dosage forms.